Yi Miao

10.2k total citations · 1 hit paper
267 papers, 6.6k citations indexed

About

Yi Miao is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yi Miao has authored 267 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Oncology, 83 papers in Molecular Biology and 82 papers in Surgery. Recurrent topics in Yi Miao's work include Pancreatic and Hepatic Oncology Research (103 papers), Pancreatitis Pathology and Treatment (42 papers) and MicroRNA in disease regulation (20 papers). Yi Miao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (103 papers), Pancreatitis Pathology and Treatment (42 papers) and MicroRNA in disease regulation (20 papers). Yi Miao collaborates with scholars based in China, United States and Belgium. Yi Miao's co-authors include Kuirong Jiang, Yicheng Ni, Jishu Wei, Zipeng Lu, Stefaan Mulier, G Marchal, Luc Michel, Yunpeng Peng, Junli Wu and Wentao Gao and has published in prestigious journals such as Angewandte Chemie International Edition, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Yi Miao

255 papers receiving 6.5k citations

Hit Papers

Complications of radiofrequency coagulation of liver tumours 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Miao China 46 2.6k 2.3k 1.7k 1.4k 1.0k 267 6.6k
Nicola Silvestris Italy 50 2.4k 0.9× 3.7k 1.6× 1.6k 1.0× 926 0.7× 1.5k 1.5× 319 7.4k
Chandan Guha United States 48 2.2k 0.9× 2.0k 0.9× 716 0.4× 1.5k 1.1× 1.4k 1.3× 267 7.1k
Noriaki Ohuchi Japan 48 3.1k 1.2× 3.4k 1.5× 2.1k 1.2× 1.2k 0.9× 1.4k 1.3× 388 9.8k
Jacques De Grève Belgium 44 3.1k 1.2× 3.4k 1.5× 1.3k 0.8× 578 0.4× 1.8k 1.7× 264 8.3k
Thierry Lecomte France 39 1.4k 0.6× 3.1k 1.4× 976 0.6× 1.4k 1.0× 1.5k 1.4× 254 6.5k
Richard Herrmann Switzerland 50 2.0k 0.8× 4.4k 2.0× 1.0k 0.6× 1.2k 0.9× 2.0k 1.9× 215 10.0k
J. Joshua Smith United States 51 3.4k 1.3× 3.6k 1.6× 1.3k 0.8× 2.1k 1.6× 2.1k 2.0× 248 10.7k
Clemens Tempfer Austria 52 1.9k 0.7× 1.9k 0.9× 978 0.6× 2.1k 1.6× 796 0.8× 374 9.2k
Koichi Matsuda Japan 56 5.7k 2.2× 2.4k 1.1× 1.7k 1.0× 917 0.7× 903 0.9× 251 11.6k
Gordon C. Jayson United Kingdom 56 4.7k 1.9× 4.1k 1.8× 2.1k 1.2× 2.2k 1.6× 2.1k 2.0× 257 14.0k

Countries citing papers authored by Yi Miao

Since Specialization
Citations

This map shows the geographic impact of Yi Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Miao more than expected).

Fields of papers citing papers by Yi Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Miao. The network helps show where Yi Miao may publish in the future.

Co-authorship network of co-authors of Yi Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Miao. A scholar is included among the top collaborators of Yi Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Miao. Yi Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Yuyang, Ruifang Chen, Yi Miao, et al.. (2025). Self‐Assembled Triple‐Targeted Radiosensitizer Enhances Hypoxic Tumor Targeting and Radio‐Immunotherapy Efficacy. Angewandte Chemie. 137(18). 3 indexed citations
2.
Guo, Meng, et al.. (2025). Biodegradable TMCM-CdCl3/polylactic acid composites for piezoelectric energy harvesting. Organic Electronics. 147. 107331–107331.
3.
Wang, Guangfu, Jin Chen, Kai Zhang, et al.. (2024). USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. Cell Death and Differentiation. 32(4). 702–713. 3 indexed citations
5.
Neoptolemos, John P., Peter J. Bailey, Christoph Springfeld, et al.. (2023). Personalized treatment in localized pancreatic cancer. European surgery. Supplement/European surgery. 56(3-4). 93–109. 5 indexed citations
6.
Miao, Yi, et al.. (2023). Hydrogen Sulfide Alleviates Lipopolysaccharide-Induced Myocardial Injury Through TLR4-NLRP3 Pathway. Physiological Research. 72(1). 15–25. 8 indexed citations
7.
Danese, Silvio, Waqqas Afif, María T. Abreu, et al.. (2023). OP15 Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension. Journal of Crohn s and Colitis. 17(Supplement_1). i19–i20. 2 indexed citations
8.
Han, Yan, Yeran Yang, Jun Yan, et al.. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene. 40(50). 6759–6771. 17 indexed citations
9.
Yin, Lingdi, Ning Pu, Elizabeth Thompson, et al.. (2020). Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis. Clinical Cancer Research. 27(3). 740–748. 38 indexed citations
10.
Zhang, Kai, Xiao Wang, Kuirong Jiang, et al.. (2020). Utilization of Mobile Application for Better Implementation of Good Clinical Practice in a Biorepository Sample Collection Process: Functions of PancMoBio in Biobanking. Biopreservation and Biobanking. 18(2). 46–52. 1 indexed citations
11.
Ge, Wanli, Qun Chen, Lingdong Meng, et al.. (2020). The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death and Disease. 11(4). 294–294. 20 indexed citations
12.
Cai, Baobao, Feng Guo, Junli Wu, et al.. (2019). Parenchyma Preserving Surgery for Idiopathic Chronic Calcific Pancreatitis in Children: A Report of Three Cases. SHILAP Revista de lepidopterología. 5(1). 51–57. 2 indexed citations
13.
Kempeneers, Marinus A., Yama Issa, Usama Ahmed Ali, et al.. (2019). International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis. Pancreatology. 20(2). 149–157. 53 indexed citations
14.
Gao, Hao, Guangfu Wang, Yong Gao, et al.. (2019). Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case–control study. Langenbeck s Archives of Surgery. 404(2). 175–182. 13 indexed citations
15.
Zhang, Jingjing, Yiyi Zhu, Kun-Ling Xie, et al.. (2014). Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Molecular Cancer. 13(1). 130–130. 94 indexed citations
16.
Miao, Yi. (2011). The "artery first"approach for resection of pancreatic head cancer. 20 indexed citations
17.
Miao, Yi, et al.. (2011). Research and Test of Key Technology in Urban Rail Transit Communication. Jisuanji gongcheng. 37(16). 251–253. 1 indexed citations
18.
Miao, Yi. (2010). China's Labor Market Integration and Economic Openness.
19.
Miao, Yi, Min Li, Jiajia Zhang, Ying Xu, & Peng Li. (2010). Resilience in China recruits and its influencing factors. Zhonghua xingwei yixue yu naokexue zazhi. 19(12). 1105–1107. 2 indexed citations
20.
Xu, Zekuan, et al.. (2004). Improved Method for Pancreaticoduodenal Transplantation in Rat Model. 18(6). 308–311.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026